Ark Invest’s purchase of Iridium Communications Inc IRDM shares via ARK Space Exploration & Innovation ETF ARKX aligns with ...
Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.
Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...
ARKK, the flagship fund of Ark Invest, has removed 187,968 shares of Palantir Technologies throughout January 2022. PLTR continues to be ARKK's fifth-largest holding with a market value at $351.9 ...
Cathie Wood is betting Donald Trump’s regulatory and growth agenda will revive the market for US initial public offerings.
Cathie Wood's ARK ETFs published their daily trades for Friday, January 31st, 2025, with a notable emphasis on the biotech sector. Leading the charge in purchases was CRISPR Therapeutics AG ...
Palantir shares moved lower in premarket trading Wednesday after falling sharply yesterday, as the stock continues to retreat from its record high set in late December. Monitor these key chart levels.